CIK 0000318306
- Non-accelerated filer
- Smaller reporting company
ABEONA THERAPEUTICS INC.
Sign in to watch- Ticker
- ABEO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 830221517
- Phone
- +1 646-813-4701
- Business address
- 6555 CARNEGIE AVE, 4TH FLOOR, CLEVELAND, OH, 44103
- Former names
- PLASMATECH BIOPHARMACEUTICALS INC, ACCESS PHARMACEUTICALS INC, CHEMEX PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $34,349
- in 1 filing
- Open-market sales, last 90 days
- $296,397
- in 5 filings
Net −$262,048. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2014-12-24 | Jeffrey B Davis Director | Purchase | +62,500 | $4.00 | $250K | 67,858 |
| 2014-12-24 | Jeffrey B Davis Director | Other acquisition | +594,801 | $4.00 | $2.4M | 662,659 |
| 2014-12-24 | Jeffrey B Davis Director | Other acquisition | +300,852 | $4.00 | $1.2M | 963,511 |
| 2014-12-24 | Jeffrey B Davis Director | Purchase · Common Stock Purchase Warrants | +62,500 | $0.01 | $625 | 62,500 |
| 2014-12-24 | Jeffrey B Davis Director | Conversion · Series A Cumulative Convertible Preferred Stock | −237.92 | $4.00 | $952 | 0 |
| 2014-12-24 | Rouhandeh Steven H Director | Purchase | +250,000 | $4.00 | $1.0M | 316,214 |
| 2014-12-24 | Rouhandeh Steven H Director | Conversion | +4,922,102 | $4.00 | $19.7M | 5,238,316 |
| 2014-12-24 | Rouhandeh Steven H Director | Conversion | +385,725 | $4.00 | $1.5M | 389,147 |
| 2014-12-24 | Rouhandeh Steven H Director | Conversion | +831,836 | $4.00 | $3.3M | 6,070,152 |
| 2014-12-24 | Rouhandeh Steven H Director | Conversion | +65,280 | $4.00 | $261K | 454,427 |
| 2014-12-24 | Rouhandeh Steven H Director | Other acquisition | +4,306,950 | $4.00 | $17.2M | 10,377,102 |
| 2014-12-24 | Rouhandeh Steven H Director | Other acquisition | +693,051 | $4.00 | $2.8M | 1,147,477 |
| 2014-12-24 | Rouhandeh Steven H Director | Other acquisition | +1,703,362 | $4.00 | $6.8M | 12,080,463 |
| 2014-12-24 | Rouhandeh Steven H Director | Other acquisition | +216,718 | $4.00 | $867K | 1,364,195 |
| 2014-12-24 | Rouhandeh Steven H Director | Purchase · Common Stock Purchase Warrants | +250,000 | $0.01 | $3K | 702,195 |
| 2014-12-24 | Rouhandeh Steven H Director | Conversion · Series A Cumulative Convertible Preferred Stock | −1,968.84 | $4.00 | $8K | 0 |
| 2014-12-24 | Rouhandeh Steven H Director | Conversion · Series A Cumulative Convertible Preferred Stock | −154.29 | $4.00 | $617 | 0 |
| 2014-12-24 | Rouhandeh Steven H Director | Other disposition · Series B Cumulative Convertible Preferred Stock | −861.39 | $4.00 | $3K | 0 |
| 2014-12-24 | Rouhandeh Steven H Director | Other disposition · Series B Cumulative Convertible Preferred Stock | −138.61 | $4.00 | $554 | 0 |
| 2014-03-07 | Howell Stephen B. Director | Grant or award · Stock Option (right to buy) | +10,000 | 10,000 |
Page 24 of 34 · 664 trades